Phase I trial of o6-benzylguanine and BCNU [carmustine ]: a biochemical modulation trial based upon depletion of o6-alkylguanine DNA alkyltransferase directed dna repair.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Benzylguanine (Primary) ; Carmustine (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 03 Mar 2010 Actual end date (Feb 2004) added as reported by ClinicalTrials.gov.
- 01 Sep 2006 Status change
- 21 Sep 2005 New trial record.